Clene Non Operating Income Net Other from 2010 to 2026

CLNN Stock  USD 5.19  0.12  2.37%   
Clene Non Operating Income Net Other yearly trend continues to be very stable with very little volatility. Non Operating Income Net Other is likely to drop to about 23.7 M. During the period from 2010 to 2026, Clene Non Operating Income Net Other quarterly data regression pattern had sample variance of 151.3 T and median of  2,293,000. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2010-12-31
Previous Quarter
25.1 M
Current Value
23.7 M
Quarterly Volatility
12.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Other Operating Expenses of 29.1 M, Total Operating Expenses of 28.9 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 118, Dividend Yield of 0.0 or Days Sales Outstanding of 456. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Build AI portfolio with Clene Stock
Check out the analysis of Clene Correlation against competitors.

Latest Clene's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Clene Inc over the last few years. It is Clene's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Slightly volatile
   Non Operating Income Net Other   
       Timeline  

Clene Non Operating Income Net Other Regression Statistics

Arithmetic Mean10,592,023
Geometric Mean5,336,161
Coefficient Of Variation116.14
Mean Deviation10,739,912
Median2,293,000
Standard Deviation12,301,091
Sample Variance151.3T
Range38.4M
R-Value0.74
Mean Square Error72.3T
R-Squared0.55
Significance0.0006
Slope1,810,108
Total Sum of Squares2421.1T

Clene Non Operating Income Net Other History

202623.7 M
202525.1 M
202221.8 M
202140.7 M

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as Non Operating Income Net Other, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Operating Income Net Other25.1 M23.7 M

Pair Trading with Clene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.

Moving against Clene Stock

  0.86VERA Vera TherapeuticsPairCorr
  0.85VNDA Vanda PharmaceuticalsPairCorr
  0.82VRTX Vertex Pharmaceuticals Earnings Call This WeekPairCorr
  0.69VRDN Viridian TherapeuticsPairCorr
  0.58DNTH Dianthus TherapeuticsPairCorr
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out the analysis of Clene Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(3.44)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.56)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.